Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Biolojic Design Appoints Roger Waltzman as Chief Medical Officer
-
Magnite and Cognitiv Announce Deep Learning Integration for Real-Time Curation
-
Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026
-
CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2025
-
Solid Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
nuVizz Advances Retail Last-Mile Delivery and Returns Excellence, Noted in the 2025 Gartner® Market Guide
-
Gentex to Highlight New Automotive Tech and Demonstrate Inroads Into New Markets at CES 2026
-
NuCana Appoints Theresa Bruce as Chief Operating Officer
-
Cadillac Escalade IQ Named 2026 MotorTrend SUV of the Year — Powered by Altia’s HMI Technology
-
Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Calvetti Ferguson Promotes Renato Antun to Tax Partner, Strengthening Nashville Market
-
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
-
Archrock Announces Private Offering of $500 Million of Senior Notes
-
Rail Vision Advances Indian Market Entry with Demonstration for Senior Governmental Officials from Multiple Government Departments
-
Centerra Gold Provides Notice of Fourth Quarter 2025 Results and Conference Call
-
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Nayax to Showcase New Digital Commerce Products for Specialty and Fashion Retail at NRF 2026
-
Rio Silver Highlights High-Grade Silver up to 6.26 g/t Au and 991 g/t Ag (28.9 oz per metric tonne) over 0.70 metres at Maria Norte and Advances a Clear Near-Term Development Path in Peru
-
Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
-
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Cognition Therapeutics Publishes Phase 2 Clinical Results Showing Zervimesine’s Potential to Slow the Progression of Dementia with Lewy Bodies
-
Silexion Therapeutics Releases CEO Letter to Shareholders Highlighting 2025’s Significant Achievements and Outlining Upcoming Milestones for 2026
-
SL Green and Rockpoint Announce Joint Venture for Ownership of 100 Park Avenue
-
PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc.
-
Centerra Gold Provides Notice of Fourth Quarter 2025 Results and Conference Call
-
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates v
-
Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities
-
Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
-
Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer
-
Edible Garden Preliminary Holiday Sales Surge 26.4% Year-Over-Year During Key Time Period
-
BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
-
Habit Brings Back Gotta Habit Meal Deals
-
Bread Financial Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call for Jan. 29
-
Reporting dates in 2026
-
Silexion Therapeutics Releases CEO Letter to Shareholders Highlighting 2025’s Significant Achievements and Outlining Upcoming Milestones for 2026
-
Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference
-
Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)
-
Alvotech announces planned CEO succession and leadership transition
-
Mark Your Calendar: Hong Kong to Host Asia’s 50 Best Restaurants 2026 after Historic Double Win
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AUCTION TECHNOLOGY GROUP - Ordinary Shares
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Riverside Insights and Prometric Join Forces to Deliver Gold-Standard Assessments to International Markets
-
Papa Johns and the CHL® Launch “Champions of Tomorrow” to Support Canada’s Young Hockey Players
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Atea Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Kymera Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
-
Crown Crafts to Participate in the ICR Conference
-
Funnel’s 2025: A year of validation + execution
-
Alesta to Highlight ALE1 Clinical Progress at 44th Annual JP Morgan Healthcare Conference
